115 related articles for article (PubMed ID: 8930418)
1. In vitro TNF-alpha, IL-2 and IFN-gamma production as markers of relapses in multiple sclerosis.
Philippé J; Debruyne J; Leroux-Roels G; Willems A; Dereuck J
Clin Neurol Neurosurg; 1996 Nov; 98(4):286-90. PubMed ID: 8930418
[TBL] [Abstract][Full Text] [Related]
2. Relapse markers in multiple sclerosis: are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations?
Debruyne J; Philippé J; Dereuck J; Willems A; Leroux-Roels G
Mult Scler; 1998 Jun; 4(3):193-7. PubMed ID: 9762673
[TBL] [Abstract][Full Text] [Related]
3. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.
Hofmann B; Bass H; Nishanian P; Faisal M; Figlin RA; Sarna GP; Fahey JL
Clin Exp Immunol; 1992 Jun; 88(3):548-54. PubMed ID: 1606739
[TBL] [Abstract][Full Text] [Related]
4. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.
Hahn G; Stuhlmüller B; Hain N; Kalden JR; Pfizenmaier K; Burmester GR
J Clin Invest; 1993 Mar; 91(3):862-70. PubMed ID: 8450066
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cancer patients with recombinant interferon-gamma induces release of endogenous tumor necrosis factor-alpha.
Aulitzky WE; Aulitzky WK; Frick J; Herold M; Gastl G; Tilg H; Berger M; Huber C
Immunobiology; 1990 Jun; 180(4-5):385-94. PubMed ID: 2118879
[TBL] [Abstract][Full Text] [Related]
6. Increased production of tumor necrosis factor alpha, and not of interferon gamma, preceding disease activity in patients with multiple sclerosis.
van Oosten BW; Barkhof F; Scholten PE; von Blomberg BM; Adèr HJ; Polman CH
Arch Neurol; 1998 Jun; 55(6):793-8. PubMed ID: 9626770
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary sarcoidosis: patterns of cytokine release in vitro.
Prior C; Knight RA; Herold M; Ott G; Spiteri MA
Eur Respir J; 1996 Jan; 9(1):47-53. PubMed ID: 8834333
[TBL] [Abstract][Full Text] [Related]
8. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
[TBL] [Abstract][Full Text] [Related]
9. Cytokine induction of neopterin production.
Henderson DC; Sheldon J; Riches P; Hobbs JR
Clin Exp Immunol; 1991 Mar; 83(3):479-82. PubMed ID: 1825941
[TBL] [Abstract][Full Text] [Related]
10. Cytokine release from cultured peripheral blood mononuclear cells of patients with severe atopic dermatitis.
Reinhold U; Pawelec G; Wehrmann W; Kukel S; Oehr P; Kreysel HW
Acta Derm Venereol; 1989; 69(6):497-502. PubMed ID: 2575322
[TBL] [Abstract][Full Text] [Related]
11. Association between biosynthesis of nitric oxide and changes in immunological and vascular parameters in patients treated with interleukin-2.
Miles D; Thomsen L; Balkwill F; Thavasu P; Moncada S
Eur J Clin Invest; 1994 Apr; 24(4):287-90. PubMed ID: 8050458
[TBL] [Abstract][Full Text] [Related]
12. Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission.
Shaw CE; Dunbar PR; Macaulay HA; Neale TJ
J Neurol; 1995 Jan; 242(2):53-8. PubMed ID: 7707089
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation.
Tilg H; Vogel W; Aulitzky WE; Herold M; Königsrainer A; Margreiter R; Huber C
Transplantation; 1990 Jun; 49(6):1074-80. PubMed ID: 2163132
[TBL] [Abstract][Full Text] [Related]
14. The in vivo immunomodulatory effects of recombinant interferon gamma plus recombinant tumor necrosis factor-alfa.
Urba WJ; Kopp WC; Clark JW; Smith JW; Steis RG; Huber C; Coggin D; Longo DL
J Clin Oncol; 1991 Oct; 9(10):1831-9. PubMed ID: 1919633
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of cytokines may play a fundamental role in the mechanisms of immunologically mediated recurrent spontaneous abortion.
Shaarawy M; Nagui AR
Acta Obstet Gynecol Scand; 1997 Mar; 76(3):205-11. PubMed ID: 9093132
[TBL] [Abstract][Full Text] [Related]
16. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
Nicoletti F; Di Marco R; Patti F; Zaccone P; L'Episcopo MR; Reggio E; Xiang M; Nicoletti A; Reggio A
Cytokine; 2000 Jun; 12(6):682-7. PubMed ID: 10843745
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients.
Küpeli E; Karnak D; Beder S; Kayacan O; Tutkak H
Respiration; 2008; 75(1):73-8. PubMed ID: 17975298
[TBL] [Abstract][Full Text] [Related]
18. Enhanced serum levels of beta-2-microglobulin, neopterin, and interferon-gamma in patients treated with recombinant tumor necrosis factor-alpha.
Aulitzky WE; Tilg H; Herold M; Berger M; Vogel W; Judmaier G; Gastl G; Mull B; Flener R; Wiegele J
J Interferon Res; 1988 Oct; 8(5):655-64. PubMed ID: 3148671
[TBL] [Abstract][Full Text] [Related]
19. Neopterin release from human endothelial cells is triggered by interferon-gamma.
Andert SE; Griesmacher A; Zuckermann A; Müller MM
Clin Exp Immunol; 1992 Jun; 88(3):555-8. PubMed ID: 1606740
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage.
Hohnoki K; Inoue A; Koh CS
J Neuroimmunol; 1998 Jul; 87(1-2):27-32. PubMed ID: 9670842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
